A Novel Scale‐Down Model Development and Viral Clearance Validation for the Periodic Counter‐Current Continuous Capture Chromatography
Biotechnology and Bioengineering · 14.11.2026
DOI: 10.1002/bit.70364 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Bioengineering, online erschienen am 14.11.2026. Verfasst von Yuqi Du und 11 weiteren Autor:innen. Beteiligte Einrichtung: WuXi Biologics Biosafety Testing (Suzhou) Co. Ltd., Suzhou, China. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The continuous capture process, with its benefits of enhanced productivity, resin utilization, and reduced footprint, has significantly saved costs. Due to the complexity of three‐column periodic counter‐current chromatography (3 C‐PCC), a represented 3‐column scale‐down model (SDM) based on conventional ÄKTA equipment is still absent for viral clearance (VC) validation. This paper established a novel tailored SDM for mimicking the flow path of 3 C‐PCC based on conventional ÄKTA equipment and then validated its viral clearance capability. Variability in input material attributes and different process phases were considered when performing viral clearance assessments in this study. Comparable LRVs were achieved across different harvest stage (including early, middle and late harvests) and process state (including start‐up, steady and close‐down states), thereby providing valuable insights for designing viral clearance validation of 3C‐PCC. Moreover, the virus distribution patterns and carryover of the ÄKTA pcc SDM were investigated and generally consistent with batch mode, and there was no detectable virus residue in any column of ÄKTA pcc SDM post sanitization. Overall, this study established a novel 3C‐PCC SDM based on conventional ÄKTA equipment and provided valuable data to support future design of 3C‐PCC viral clearance validation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- WuXi Biologics Biosafety Testing (Suzhou) Co. Ltd., Suzhou, China.
- WuXi Biologics (Shanghai) Co. Ltd., Shanghai, China.
ORCID-Profile: Yuqi Du, Yifeng Li, Hang Zhou, Tianle Qian, Shanshan Wu
Zitieren
APA
Du, Y., Chang, Q., Wang, S., Jing, S., Yang, D., Cheng, H., Li, Y., Zhou, H., Chen, Y., Qian, T., Wu, S., & Tong, Y. (2026). A Novel Scale‐Down Model Development and Viral Clearance Validation for the Periodic Counter‐Current Continuous Capture Chromatography. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.70364
Vancouver
Du Y, Chang Q, Wang S, Jing S, Yang D, Cheng H, et al. A Novel Scale‐Down Model Development and Viral Clearance Validation for the Periodic Counter‐Current Continuous Capture Chromatography. Biotechnology and Bioengineering. 2026. doi:10.1002/bit.70364
BibTeX
@article{Du2026,
author = {Du, Yuqi and Chang, Qing and Wang, Shanshan and Jing, Shuying and Yang, Daguo and Cheng, Huan and Li, Yifeng and Zhou, Hang and Chen, Yuanyuan and Qian, Tianle and Wu, Shanshan and Tong, Yong},
title = {A Novel Scale‐Down Model Development and Viral Clearance Validation for the Periodic Counter‐Current Continuous Capture Chromatography},
journal = {Biotechnology and Bioengineering},
year = {2026},
doi = {10.1002/bit.70364}
}
EUVIMED